Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Net Margin (2024 - 2025)

Kura Oncology (KURA) has disclosed Net Margin for 2 consecutive years, with 467.23% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 473497.0% to 467.23% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 412.95% through Dec 2025, down 1103463.0% year-over-year, with the annual reading at 412.95% for FY2025, 9006.0% down from the prior year.
  • Net Margin for Q4 2025 was 467.23% at Kura Oncology, down from 357.19% in the prior quarter.
  • The five-year high for Net Margin was 13204.85% in Q3 2024, with the low at 467.23% in Q4 2025.